» Articles » PMID: 27991918

Dissociation of Muscle Insulin Sensitivity from Exercise Endurance in Mice by HDAC3 Depletion

Abstract

Type 2 diabetes and insulin resistance are associated with reduced glucose utilization in the muscle and poor exercise performance. Here we find that depletion of the epigenome modifier histone deacetylase 3 (HDAC3) specifically in skeletal muscle causes severe systemic insulin resistance in mice but markedly enhances endurance and resistance to muscle fatigue, despite reducing muscle force. This seemingly paradoxical phenotype is due to lower glucose utilization and greater lipid oxidation in HDAC3-depleted muscles, a fuel switch caused by the activation of anaplerotic reactions driven by AMP deaminase 3 (Ampd3) and catabolism of branched-chain amino acids. These findings highlight the pivotal role of amino acid catabolism in muscle fatigue and type 2 diabetes pathogenesis. Further, as genome occupancy of HDAC3 in skeletal muscle is controlled by the circadian clock, these results delineate an epigenomic regulatory mechanism through which the circadian clock governs skeletal muscle bioenergetics. These findings suggest that physical exercise at certain times of the day or pharmacological targeting of HDAC3 could potentially be harnessed to alter systemic fuel metabolism and exercise performance.

Citing Articles

Enzyme-independent functions of HDAC3 in the adult heart.

Qian S, Zhang C, Li W, Song S, Lin G, Cheng Z bioRxiv. 2025; .

PMID: 39803453 PMC: 11722435. DOI: 10.1101/2024.12.29.630635.


Proteomic insights into circadian transcription regulation: novel E-box interactors revealed by proximity labeling.

Torres M, Kirchner M, Marks C, Mertins P, Kramer A Genes Dev. 2024; 38(21-24):1020-1032.

PMID: 39562139 PMC: 11610934. DOI: 10.1101/gad.351836.124.


Branched-chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases.

Mansoori S, Ho M, Ng K, Cheng K Obes Rev. 2024; 26(2):e13856.

PMID: 39455059 PMC: 11711082. DOI: 10.1111/obr.13856.


HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients.

Mozzetta C, Sartorelli V, Steinkuhler C, Puri P Trends Mol Med. 2024; 30(3):278-294.

PMID: 38408879 PMC: 11095976. DOI: 10.1016/j.molmed.2024.01.007.


Role of AMP deaminase in diabetic cardiomyopathy.

Miura T, Kouzu H, Tanno M, Tatekoshi Y, Kuno A Mol Cell Biochem. 2024; 479(12):3195-3211.

PMID: 38386218 DOI: 10.1007/s11010-024-04951-z.


References
1.
Sun Z, Miller R, Patel R, Chen J, Dhir R, Wang H . Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med. 2012; 18(6):934-42. PMC: 3411870. DOI: 10.1038/nm.2744. View

2.
Bass J, Takahashi J . Circadian integration of metabolism and energetics. Science. 2010; 330(6009):1349-54. PMC: 3756146. DOI: 10.1126/science.1195027. View

3.
Woldt E, Sebti Y, Solt L, Duhem C, Lancel S, Eeckhoute J . Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med. 2013; 19(8):1039-46. PMC: 3737409. DOI: 10.1038/nm.3213. View

4.
Schiaffino S, Reggiani C . Fiber types in mammalian skeletal muscles. Physiol Rev. 2011; 91(4):1447-531. DOI: 10.1152/physrev.00031.2010. View

5.
Bruning J, Michael M, Winnay J, Hayashi T, Horsch D, Accili D . A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998; 2(5):559-69. DOI: 10.1016/s1097-2765(00)80155-0. View